Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biopsybell is an Italian private medical device company, also branded as BPB Medica, focused on the design, manufacture, and commercialization of minimally invasive surgical and healthcare products. Its portfolio spans biopsy devices, spine intervention systems, ortho-biologics and regenerative medicine kits, assisted reproduction products, intensive care consumables, and aesthetic medicine tools. The company emphasizes vertically integrated, in-house production and sells single-use and procedure-specific devices to support physicians in hospital and specialty care settings. Founded in 1999 and headquartered in Mirandola, Italy, Biopsybell appears to be an active commercial-stage healthcare manufacturer rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biopsybell.